BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21995957)

  • 1. Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice.
    Baltgalvis KA; Jaeger MA; Fitzsimons DP; Thayer SA; Lowe DA; Ervasti JM
    Skelet Muscle; 2011 Oct; 1(1):32. PubMed ID: 21995957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.
    Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM
    FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle-specific ablation of gamma(cyto)-actin does not exacerbate the mdx phenotype.
    Prins KW; Lowe DA; Ervasti JM
    PLoS One; 2008 Jun; 3(6):e2419. PubMed ID: 18545671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
    Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
    J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle.
    Olthoff JT; Lindsay A; Abo-Zahrah R; Baltgalvis KA; Patrinostro X; Belanto JJ; Yu DY; Perrin BJ; Garry DJ; Rodney GG; Lowe DA; Ervasti JM
    Nat Commun; 2018 Nov; 9(1):5104. PubMed ID: 30504831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
    Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
    Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
    Martin PT; Xu R; Rodino-Klapac LR; Oglesbay E; Camboni M; Montgomery CL; Shontz K; Chicoine LG; Clark KR; Sahenk Z; Mendell JR; Janssen PM
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C476-88. PubMed ID: 19109526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice.
    Lynch GS; Rafael JA; Chamberlain JS; Faulkner JA
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1290-4. PubMed ID: 11003610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive strength gains in dystrophic muscle exposed to repeated bouts of eccentric contraction.
    Call JA; Eckhoff MD; Baltgalvis KA; Warren GL; Lowe DA
    J Appl Physiol (1985); 2011 Dec; 111(6):1768-77. PubMed ID: 21960659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse.
    Yeung EW; Whitehead NP; Suchyna TM; Gottlieb PA; Sachs F; Allen DG
    J Physiol; 2005 Jan; 562(Pt 2):367-80. PubMed ID: 15528244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of Ca²⁺ entry and cytoskeletal damage following eccentric contractions in mouse skeletal muscle.
    Zhang BT; Whitehead NP; Gervasio OL; Reardon TF; Vale M; Fatkin D; Dietrich A; Yeung EW; Allen DG
    J Appl Physiol (1985); 2012 Jun; 112(12):2077-86. PubMed ID: 22461447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.
    Hanft LM; Bogan DJ; Mayer U; Kaufman SJ; Kornegay JN; Ervasti JM
    Neuromuscul Disord; 2007 Jul; 17(7):569-74. PubMed ID: 17475492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of iPLA2 β and of stretch-activated channels by doxorubicin alters dystrophic muscle function.
    Ismail HM; Dorchies OM; Perozzo R; Strosova MK; Scapozza L; Ruegg UT
    Br J Pharmacol; 2013 Aug; 169(7):1537-50. PubMed ID: 23849042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle.
    Ljubicic V; Miura P; Burt M; Boudreault L; Khogali S; Lunde JA; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2011 Sep; 20(17):3478-93. PubMed ID: 21659335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy.
    Blaauw B; Agatea L; Toniolo L; Canato M; Quarta M; Dyar KA; Danieli-Betto D; Betto R; Schiaffino S; Reggiani C
    J Appl Physiol (1985); 2010 Jan; 108(1):105-11. PubMed ID: 19910334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice.
    Whitehead NP; Streamer M; Lusambili LI; Sachs F; Allen DG
    Neuromuscul Disord; 2006 Dec; 16(12):845-54. PubMed ID: 17005404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions.
    Chan S; Head SI; Morley JW
    Am J Physiol Cell Physiol; 2007 Sep; 293(3):C985-92. PubMed ID: 17567750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
    Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-dependent functional substitution of alpha-skeletal actin by gamma-cytoplasmic actin.
    Jaeger MA; Sonnemann KJ; Fitzsimons DP; Prins KW; Ervasti JM
    FASEB J; 2009 Jul; 23(7):2205-14. PubMed ID: 19279140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.